Position in INSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,730,122
-$975,316 QoQ
Shares Held
16,227
-1.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#296
of 663 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gulf International Bank (UK) Ltd holds $25,646,508 across 7 Biotechnology names. INSM ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,389 | $10,127,827 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,856 | $4,898,530 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,046 | $3,024,147 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
14,362 | $2,689,715 | |
| 5 | RPRX |
Royalty Pharma plc
|
30,958 | $1,735,815 | |
| 6 | INSM |
INSMED Inc
This page
|
16,227 | $1,730,122 | |
| 7 | INCY |
Incyte Corp
|
12,706 | $1,440,352 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,730,122 | 16,227 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,705,438 | 16,545 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,920,183 | 11,033 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||